This ADC product is composed of an anti-EGFR antibody (clone J2898A) conjugated via SMCC linker to DM1 (J2898A-SMCC-DM1). It is in Phase I clinical trials and has demonstrated a response in Solid tumors treatment by a MOA (Mechanism of Action) of microtubules depolymerizing.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.